ResultsIQ

ResultsIQ › Latest results › Sudarshan Chemical Industries Limited

Sudarshan Chemical Industries Limited Q4 FY25 earnings call summary

NSE: SUDARSCHEM · BSE: 506655

Earnings call of 29 Jul 2025, summarised by AI from the filing.

One Sudarshan Q4 FY25 sales ₹1,349 cr and adjusted EBITDA ₹148 cr; acquired group EBITDA guided at EUR35 million this year.

Key takeaways

  1. Q4 FY25 One Sudarshan sales ₹1,349 cr (Q4 FY24: ₹764 cr); adjusted EBITDA ₹148 cr (Q4 FY24: ₹119 cr).
  2. Guidance Acquired group EBITDA guided at EUR35 million this year, after integration cost, if no force majeure.
  3. Change Heubach acquired group consolidated for the first time, adding March sales ₹525 cr and EBITDA ₹22 cr.
  4. Driver Cost reduction initiatives to continue 18 months and winning back lost business to build EBITDA.
  5. Risk Flat demand and destocking amid geopolitical and tariff uncertainty.

Original filing on BSE

Sudarshan Chemical Industries Limited Q1 FY27 results

As filed: Revenue ₹2,642 cr (+5% year on year), EBITDA ₹259 cr (+35% year on year), PAT ₹103 cr (+88% year on year), EBITDA margin 9.8% (+214 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹733 cr (+4% year on year), EBITDA ₹152 cr (+117% year on year), PAT ₹120 cr (+300% year on year), EBITDA margin 20.7% (+1,000 bps). Score 76 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 1000 bps year on year. Tax rate 11%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −14.5% in 30 days (Nifty 500: +0.9%).
  • Q3 FY26: Revenue ₹2,103 cr (+216% year on year), EBITDA ₹37.9 cr (−53% year on year), PAT −₹116 cr (−300% year on year), EBITDA margin 1.8% (−1,000 bps). Score 20 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 1000 bps year on year. Consolidated profit -11700% but standalone +41%. Revenue fell 12% from last quarter. Revenue rose ₹1,437 cr on a year ago, more than the ₹100 cr it added the year before. Share price after the results: −11.3% in 29 days (Nifty 500: −9.6%).
  • Q2 FY26: Revenue ₹2,387 cr (+243% year on year), EBITDA ₹132 cr (+39% year on year), PAT ₹19.0 cr (−37% year on year), EBITDA margin 5.5% (−812 bps). Score 39 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 812 bps year on year. Other income 145% of PBT. Tax rate 55%. Consolidated profit -37% but standalone +21%. Revenue fell 5% from last quarter. Revenue rose ₹1,691 cr on a year ago, more than the ₹95.0 cr it added the year before. Share price after the results: −14.6% in 30 days (Nifty 500: +3.4%).
  • Q1 FY26: Revenue ₹2,507 cr (+295% year on year), EBITDA ₹192 cr (+140% year on year), PAT ₹55.0 cr (+90% year on year), EBITDA margin 7.7% (−496 bps). Score 62 of 100, In line with trend. Revenue and EBITDA growth were well above the company's own trend; profit growth was in line with it. EBITDA margin fell 496 bps year on year. Other income 35% of PBT. Tax rate 37%. Share price after the results: +12.7% in 29 days (Nifty 500: −1.3%).
  • Q4 FY25: Revenue ₹704 cr (+14% year on year), EBITDA ₹70.0 cr (−22% year on year), PAT ₹22.0 cr (−15% year on year), EBITDA margin 9.9% (−462 bps). Score 22 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 462 bps year on year. Other income 50% of PBT. Revenue rose ₹86.0 cr on a year ago, more than the ₹76.0 cr it added the year before. Share price after the results: +14.5% in 28 days (Nifty 500: +3.3%).
  • Q3 FY25: Revenue ₹666 cr (+18% year on year), EBITDA ₹80.0 cr (+29% year on year), PAT ₹1.0 cr (+64% year on year), EBITDA margin 12.0% (+106 bps). Score 40 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit before exceptional items growth were below it. EBITDA margin rose 106 bps year on year. Other income 80% of PBT. Tax rate 80%. Revenue fell 4% from last quarter.
  • Q2 FY25: Revenue ₹696 cr (+16% year on year), EBITDA ₹95.0 cr (+46% year on year), PAT ₹30.0 cr (+108% year on year), EBITDA margin 13.7% (+283 bps). Score 82 of 100, Above trend. EBITDA margin rose 283 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Sudarshan Chemical Industries Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.